Comparison of the Therapeutic Efficacy of Rhizoma Alismatis, Fructus Crataegi, Fructus Lycii, Radix Curcumae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae on the Experimental Cellular Model of Nonalcoholic Fatty Liver Disease

비알코올성 지방간 세포 모델에 대한 택사, 산사, 구기자, 울금, 단삼, 인진의 효능 비교

  • Han, Chang-Woo (Dept. of Internal Medicine, School of Korean Medicine, Pu-San National University) ;
  • Joo, Myung-Soo (Division of Applied Medicine, School of Korean Medicine, Pu-San National University) ;
  • Lee, Jang-Hoon (Dept. of Internal Medicine, College of Korean Medicine, Kyung-Hee University)
  • 한창우 (부산대학교 한의학전문대학원 내과학교실) ;
  • 주명수 (부산대학교 한의학전문대학원 응용의학부) ;
  • 이장훈 (경희대학교 한의과대학 간계내과학교실)
  • Published : 2012.12.30

Abstract

Objectives : We try to compared the efficacy of six herbal medicines, Rhizoma Alismatis (RA), Fructus Crataegi (FC), Fructus Lycii (FL), Radix Curcumae (RC), Radix Salviae Miltiorrhizae (RSM), and Herba Artemisiae Scopariae (HAS), constituting KHchunggan-tang which was previously proven to be hepatoprotective on non-alcoholic fatty liver disease with combined properties of cellular steatosis, ROS production, and cytoprotection. Methods : HepG2 cells were pretreated with aqueous extracts of the six herb medicines at concentrations of 1, 10, 50 and 100 ${\mu}g/ml$ each, and treated with 0.5 mM palmitate consecutively. After 21 hrs, cell viability was assessed using MTT assay, and the percentage of cells with sub-G1 DNA content was measured using fluorescence-activated cell sorting after propidium iodide staining. Results : The first three extracts, RA, FC, and FL restored cell viability reduced by palmitate in MTT assay, and RA, FC, FL and RC inhibited palmitate-induced apoptosis in sub-G1 analysis. FL showed relatively weak potential only at tested maximal dose, and RA showed the greatest higher efficacy on this experimental cellular model of nonalcoholic fatty liver disease. Conclusions : According to this comparative experiment, Rhizoma Alismatis seems to have the most powerful potential among the six herbs constituting KHchunggan-tang, and consecutive further study seems to be required for more standardized and effective clinical application of KHchunggan-tang for treatment of non-alcoholic fatty liver disease.

Keywords

References

  1. Prasad H, Ryan DA, Celzo MF, Stapleton D. Metabolic syndrome: definition and therapeutic implications. Postgrad Med 2012;124(1):21-30. https://doi.org/10.3810/pgm.2012.01.2514
  2. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94(9):2467-74. https://doi.org/10.1111/j.1572-0241.1999.01377.x
  3. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006;21(1Pt1): 138-43. https://doi.org/10.1111/j.1440-1746.2005.04086.x
  4. Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, et al. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol Assess 2011;15(38):1-110.
  5. Han CW, Lee JH. Effects of KHchunggan-tang on the nonalcoholic fatty liver disease in palmitate-induced cellular model. J Korean Oriental Med 2011;32(1):109-20.
  6. Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006;82(967): 315-22. https://doi.org/10.1136/pgmj.2005.042200
  7. Wu JN. An illustrated Chinese materia medica. New York: Oxford University Press; 2005, p. 59, 111, 225, 235, 403, 565.
  8. Hong X, Tang H, Wu L, Li L. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. J Pharm Pharmacol 2006;58(10):1391-8. https://doi.org/10.1211/jpp.57.10.0013
  9. Han CW, Kang ES, Ham SA, Woo HJ, Lee JH, Seo HG. Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury. Pharm Biol 2012;50(10):1281-8. https://doi.org/10.3109/13880209.2012.673629
  10. Lin HR. Triterpenes from Alisma orientalis act as farnesoid X receptor agonists. Bioorg Med Chem Lett 2012;22(14):4787-92. https://doi.org/10.1016/j.bmcl.2012.05.057
  11. Li HB, Fang KY, Lu CT, Li XE. [Study on lipid-regulating function for the extracts and their prescriptions from Semen Cassiae and fructus crataegi]. Zhong yao cai 2007;30(5): 573-5.
  12. Niu C, Chen C, Chen L, Cheng K, Yeh C, Cheng J. Decrease of blood lipids induced by Shan-Zha (fruit of Crataegus pinnatifida) is mainly related to an increase of PPARalpha in liver of mice fed high-fat diet. Horm Metab Res 2011;43(9):625-30. https://doi.org/10.1055/s-0031-1283147
  13. Wu HT, He XJ, Hong YK, Ma T, Xu YP, Li HH. Chemical characterization of Lycium barbarum polysaccharides and its inhibition against liver oxidative injury of high-fat mice. Int J Biol Macromol 2010;46(5):540-3. https://doi.org/10.1016/j.ijbiomac.2010.02.010
  14. Zhao R, Li Q, Xiao B. Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats. Yakugaku Zasshi 2005;125(12):981-8. https://doi.org/10.1248/yakushi.125.981
  15. Luo Q, Cai Y, Yan J, Sun M, Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004;76(2):137-49. https://doi.org/10.1016/j.lfs.2004.04.056
  16. Shin JH, Kang MJ, Yang SM, Lee SJ, sung NJ. Effects of namhae specialized crops water extract on lipid metabolism in rats fed a cholesterol diet. Korean J Food Cookery Sci 2011;27(5):599-610. https://doi.org/10.9724/kfcs.2011.27.5.599
  17. Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 2005;11(7):BR228-34.
  18. Zhang ZP, You TT, Zou LY, Wu T, Wu Y, Cui L. [Effect of a compound Danshen preparation in preventing long-term gastric lipid emulsion administration-induced nonalcoholic steatohepatitis in rats]. Nan Fang Yi Ke Da Xue Xue Bao 2008;28(7):1109-13.
  19. Ji W, Gong BQ. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. J Ethnopharmacol 2008;119(2):291-8. https://doi.org/10.1016/j.jep.2008.07.013
  20. Kang DG, Yun YG, Ryoo JH, Lee HS. Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am J Chin Med 2002;30(1):87-93. https://doi.org/10.1142/S0192415X02000107
  21. Liu G, Guan GJ, Qi TG, Fu YQ, Li XG, Sun Y, et al. [Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism]. Zhong Xi Yi Jie He Xue Bao 2005;3(6):459-62. https://doi.org/10.3736/jcim20050610
  22. Kim SK, Jung KH, Lee BC. Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy. Biol Pharm Bull 2009;32(2):220-4. https://doi.org/10.1248/bpb.32.220
  23. Okuno I, Uchida K, Kadowaki M, Akahori A. Choleretic effect of Artemisia capillaris extract in rats. Jpn J Pharmacol 1981;31(5):835-8. https://doi.org/10.1254/jjp.31.835
  24. Hong JH, Hwang EY, Kim HJ, Jeong YJ, Lee IS. Artemisia capillaris inhibits lipid accumulation in 3T3-L1 adipocytes and obesity in C57BL/6J mice fed a high fat diet. J Med Food 2009; 12(4):736-45. https://doi.org/10.1089/jmf.2008.1240
  25. Pan J, Liu G, Liu H, Qiu Z, Chen L. [Effects of artemisia capillaris on blood glucose and lipid in mice]. Zhong Yao Cai 1998;21(8):408-11.